HAIM
ABBV icon

Hunter Associates Investment Management’s AbbVie ABBV Stock Holding History

Hunter Associates Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.83M Buy
23,181
+96
+0.4% +$20.7K 0.67% 34
2026
Q1 		$5.02M Sell
23,085
-11
-0% -$2.44K 0.66% 35
2025
Q4 		$5.28M Sell
23,096
-392
-2% -$89.3K 0.71% 33
2025
Q3 		$5.44M Buy
23,488
+267
+1% +$54.4K 0.76% 31
2025
Q2 		$4.31M Sell
23,221
-349
-1% -$64.9K 0.64% 35
2025
Q1 		$4.94M Sell
23,570
-91
-0.4% -$17.7K 0.76% 32
2024
Q4 		$4.21M Sell
23,661
-194
-0.8% -$35.7K 0.64% 33
2024
Q3 		$4.71M Sell
23,855
-415
-2% -$77.5K 0.73% 31
2024
Q2 		$4.16M Sell
24,270
-633
-3% -$105K 0.7% 31
2024
Q1 		$4.54M Buy
24,903
+1,177
+5% +$203K 0.76% 31
2023
Q4 		$3.67M Sell
23,726
-445
-2% -$64.9K 0.67% 40
2023
Q3 		$3.61M Sell
24,171
-83
-0.3% -$12.2K 0.73% 35
2023
Q2 		$3.26M Sell
24,254
-410
-2% -$60.1K 0.64% 42
2023
Q1 		$3.93M Sell
24,664
-836
-3% -$128K 0.84% 32
2022
Q4 		$4.11M Sell
25,500
-3,347
-12% -$513K 0.99% 25
2022
Q3 		$3.87M Sell
28,847
-314
-1% -$45.1K 1% 26
2022
Q2 		$4.46M Buy
29,161
+10,061
+53% +$1.54M 1.1% 24
2022
Q1 		$3.1M Sell
19,100
-500
-3% -$72.6K 1% 22
2021
Q4 		$2.65M Buy
19,600
+5,100
+35% +$602K 0.76% 30
2021
Q3 		$1.56M Hold
14,500
– – 0.5% 43
2021
Q2 		$1.63M Sell
14,500
-10,141
-41% -$1.14M 0.51% 42
2021
Q1 		$2.67M Buy
24,641
+1,190
+5% +$127K 0.62% 44
2020
Q4 		$2.51M Buy
23,451
+1,767
+8% +$170K 0.62% 41
2020
Q3 		$1.9M Buy
21,684
+710
+3% +$66.8K 0.53% 46
2020
Q2 		$2.06M Sell
20,974
-1,100
-5% -$96.8K 0.61% 39
2020
Q1 		$1.68M Buy
22,074
+3,952
+22% +$337K 0.65% 41
2019
Q4 		$1.6M Sell
18,122
-45
-0.2% -$3.74K 0.5% 51
2019
Q3 		$1.38M Buy
18,167
+175
+1% +$12K 0.47% 51
2019
Q2 		$1.31M Buy
17,992
+325
+2% +$25.5K 0.45% 54
2019
Q1 		$1.42M Buy
17,667
+700
+4% +$57.3K 0.5% 54
2018
Q4 		$1.56M Buy
16,967
+250
+1% +$22K 0.64% 41
2018
Q3 		$1.58M Buy
16,717
+300
+2% +$28.4K 0.55% 50
2018
Q2 		$1.52M Sell
16,417
-100
-0.6% -$9.77K 0.55% 49
2018
Q1 		$1.56M Buy
16,517
+275
+2% +$30.2K 0.58% 46
2017
Q4 		$1.57M Hold
16,242
– – 0.58% 46
2017
Q3 		$1.44M Sell
16,242
-50
-0.3% -$3.81K 0.56% 47
2017
Q2 		$1.18M Buy
16,292
+267
+2% +$17.9K 0.48% 53
2017
Q1 		$1.04M Hold
16,025
– – 0.44% 56
2016
Q4 		$1M Buy
16,025
+400
+3% +$24.4K 0.43% 57
2016
Q3 		$985K Sell
15,625
-890
-5% -$57.6K 0.42% 58
2016
Q2 		$1.02M Hold
16,515
– – 0.44% 59
2016
Q1 		$943K Hold
16,515
– – 0.43% 59
2015
Q4 		$978K Buy
16,515
+200
+1% +$11.5K 0.43% 54
2015
Q3 		$888K Sell
16,315
-75
-0.5% -$4.88K 0.42% 55
2015
Q2 		$1.1M Hold
16,390
– – 0.46% 51
2015
Q1 		$959K Sell
16,390
-500
-3% -$30.2K 0.38% 65
2014
Q4 		$1.1M Sell
16,890
-400
-2% -$25.2K 0.43% 58
2014
Q3 		$999K Sell
17,290
-135
-0.8% -$7.5K 0.39% 63
2014
Q2 		$983K Hold
17,425
– – 0.39% 63
2014
Q1 		$896K Sell
17,425
-4,455
-20% -$225K 0.35% 66
2013
Q4 		$1.16M Buy
21,880
+100
+0.5% +$4.92K 0.44% 57
2013
Q3 		$974K Sell
21,780
-11,105
-34% -$492K 0.41% 59
2013
Q2 		$1.36M Buy
+32,885
New +$1.44M 0.5% 52

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Hunter Associates Investment Management's ABBV Position: Q2 2026 in Review

Hunter Associates Investment Management increased its AbbVie (ABBV) stake by 0.42% in Q2 2026, buying an estimated $20.7K and bringing the position to 23,181 shares worth $5.83M. The position accounts for 0.67% of the portfolio, ranked #34.

Hunter Associates Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hunter Associates Investment Management held 23,181 shares of AbbVie worth $5.83M as of Q2 2026.
  • Hunter Associates Investment Management bought 96 AbbVie shares in Q2 2026, an estimated $20.7K.
  • AbbVie made up 0.67% of Hunter Associates Investment Management's portfolio in Q2 2026, its #34 holding.
  • Hunter Associates Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.